1.

Center for Middle Eastern Studies Newsletter No. 28 (Fall 2001/Spring 2002)

2.

Center for Middle Eastern Studies Newsletter No. 28 (Fall 2001/Spring 2002)

3.

Center for Middle Eastern Studies Newsletter No. 28 (Fall 2001/Spring 2002)

4.

Center for Middle Eastern Studies Newsletter No. 28 (Fall 2001/Spring 2002)

1.

Raw data from 4.27 ka Bonaire coral, sample BON-4-G

2.

Raw data from 4.27 ka Bonaire coral, sample BON-4-G

3.

Raw data from 4.27 ka Bonaire coral, sample BON-4-G

4.

Raw data from 4.27 ka Bonaire coral, sample BON-4-G

1.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

2.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

3.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

4.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

5.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

6.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

7.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

8.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

9.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

1.

[Col. Jay W. Grissinger and Staff] [Office of Chief Surgeon, Army of Occupation, Coblenz, Germany].

2.

[Col. Jay W. Grissinger and Staff] [Office of Chief Surgeon, Army of Occupation, Coblenz, Germany].

3.

[Col. Jay W. Grissinger and Staff] [Office of Chief Surgeon, Army of Occupation, Coblenz, Germany].

4.

[Col. Jay W. Grissinger and Staff] [Office of Chief Surgeon, Army of Occupation, Coblenz, Germany].

1.

1957 football team; 1957 Oregon Webfoots

2.

1957 football team; 1957 Oregon Webfoots

3.

1957 football team; 1957 Oregon Webfoots

4.

1957 football team; 1957 Oregon Webfoots

1.

1957 football team

2.

1957 football team

3.

1957 football team

4.

1957 football team

1.

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media

2.

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media

3.

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media

4.

Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media

1.

Image_1_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

2.

Image_1_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

3.

Image_1_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

4.

Image_1_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

1.

Image_2_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

2.

Image_2_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

3.

Image_2_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

4.

Image_2_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.pdf

1.

Image_3_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.jpeg

2.

Image_3_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.jpeg

3.

Image_3_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.jpeg

4.

Image_3_Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.jpeg